Tag egfr [at least 200 articles] Export

Recent papers classified by the tag egfr.

	An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors [My Copy] Oncogene, Vol. 28, No. 31. (15 June 2009), pp. 2773-2783. by D. Chitale, Y. Gong, B. S. Taylor, et al.S. Broderick, C. Brennan, R. Somwar, B. Golas, L. Wang, N. Motoi, J. Szoke, J. M. Reinersman, J. Major, C. Sander, V. E. Seshan, M. F. Zakowski, V. Rusch, W. Pao, W. Gerald, M. Ladanyi posted to mutation lung_cancer kras integration egfr copy-number by jfr on 2009-11-25 11:46:17 as along with 1 person frohike
	The Epidermal Growth Factor Receptor: From Mutant Oncogene in Nonhuman Cancers to Therapeutic Target in Human Neoplasia [My Copy] J Clin Oncol, Vol. 19, No. suppl_1. (15 September 2001), pp. 32s-40. by Carlos L. Arteaga posted to egfr by JHRRNMS on 2009-11-21 16:24:15 as
	Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? [My Copy] BMC Cancer, Vol. 9, No. 1. (01 January 2009), 1. by Dara Kavanagh, Gillian Chambers, Liam O. Grady, et al.Kevin Barry, Ronan Waldron, Fadel Bennani, Paul Eustace, Iqdam Tobbia posted to egfr biology by JHRRNMS on 2009-11-21 16:04:39 as
	Epidermal growth factor receptor signaling in liver cell proliferation and apoptosis. [My Copy] Biological chemistry, Vol. 390, No. 10. (October 2009), pp. 1033-1037. by Roland Reinehr, Dieter Häussinger posted to hepatocyte egfr by guhjy on 2009-11-21 15:09:24 as
	Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 46. (17 November 2009), pp. 19503-19508. by Anthony C. Faber, Danan Li, YoungChul Song, et al.Mei-Chih Liang, Beow Y. Yeap, Roderick T. Bronson, Eugene Lifshits, Zhao Chen, Sauveur-Michel Maira, Carlos GarcÃa-EcheverrÃa, Kwok-Kin Wong, Jeffrey A. Engelman posted to small lung her2 faber09pdf egfr cell cancer apoptosis by paulschlesinger on 2009-11-18 02:19:13 as
	A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer. [My Copy] BMC cancer, Vol. 9, No. 1. (13 May 2009), 145. by Justin M. Balko, Esther P. Black posted to therapy gene_expression egfr colon_cancer classification cetuximab by jfr on 2009-11-15 14:27:04 as along with 1 person frohike
	Targeting the EGFR and the PKB pathway in cancer. [My Copy] Current opinion in cell biology, Vol. 21, No. 2. (April 2009), pp. 185-193. by Shoshana Klein, Alexander Levitzki posted to rsk inhibitor egfr cancer akt by guhjy on 2009-11-13 02:13:33 as
	Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. [My Copy] The Journal of biological chemistry, Vol. 274, No. 52. (24 December 1999), pp. 36843-36851. by S. Eguchi, H. Iwasaki, H. Ueno, et al.G. D. Frank, E. D. Motley, K. Eguchi, F. Marumo, Y. Hirata, T. Inagami posted to vsmc s6k erk egfr eas akt aii by guhjy on 2009-11-11 06:12:56 as
	Role of growth factors in diabetic kidney disease. [My Copy] Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme, Vol. 41, No. 8. (August 2009), pp. 585-593. by F. Chiarelli, S. Gaspari, M. L. Marcovecchio posted to tgfb gf egfr dn by guhjy on 2009-11-10 04:32:44 as
	The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data. [My Copy] PLoS computational biology, Vol. 5, No. 8. (7 August 2009), e1000438. by Regina Samaga, Julio Saez-Rodriguez, Leonidas G. Alexopoulos, Peter K. Sorger, Steffen Klamt posted to signaling hts egfr by guhjy on 2009-11-09 04:56:51 as along with 3 people mstumpf ptrobajo frohike
	Receptor tyrosine kinase signaling: a view from quantitative proteomics. [My Copy] Molecular bioSystems, Vol. 5, No. 10. (October 2009), pp. 1112-1121. by Joern Dengjel, Irina Kratchmarova, Blagoy Blagoev posted to rtk proteomics egfr by guhjy on 2009-11-09 04:49:11 as
	American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 12. (20 April 2009), pp. 2091-2096. by Carmen J. Allegra, J. Milburn Jessup, Mark R. Somerfield, et al.Stanley R. Hamilton, Elizabeth H. Hammond, Daniel F. Hayes, Pamela K. McAllister, Roscoe F. Morton, Richard L. Schilsky posted to therapy mutation kras egfr colon_cancer by jfr on 2009-11-08 23:07:40 as along with 1 person brainsman2000
	Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers [My Copy] Seminars in Oncology, Vol. 29, No. 1. (February 2002), pp. 27-36. by R. Herbst posted to mgcb kinases egfr cancer by kokphinchooi on 2009-11-06 05:51:20 as along with 1 person baraksch
	EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy [My Copy] Science, Vol. 304, No. 5676. (4 June 2004), pp. 1497-1500. by J. Guillermo Paez, Pasi A. Janne, Jeffrey C. Lee, et al.Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J. Kaye, Neal Lindeman, Titus J. Boggon, Katsuhiko Naoki, Hidefumi Sasaki, Yoshitaka Fujii, Michael J. Eck, William R. Sellers, Bruce E. Johnson, Matthew Meyerson posted to nonsmall_cell_lung_cancer mgcb kinases gefitinib egfr biological_action by kokphinchooi on 2009-11-06 05:47:51 as
	The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases [My Copy] Il Farmaco, Vol. 56, No. 1-2. (1 March 2001), pp. 51-56. by W. Denny posted to mgcb kinases egfr biological_action by kokphinchooi on 2009-11-04 19:14:39 as
	Review of epidermal growth factor receptor biology [My Copy] International Journal of Radiation OncologyBiologyPhysics, Vol. 59, No. 2. (June 2004), pp. S21-S26. by R. Herbst posted to mgcb kinases egfr biological_action by kokphinchooi on 2009-11-04 19:13:30 as
	Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. [My Copy] Journal of Biological Chemistry, Vol. 265, No. 3. (25 January 1990), pp. 1750-1754. by G. M. Walton, W. S. Chen, M. G. Rosenfeld, G. N. Gill posted to mgcb kinases egfr by kokphinchooi on 2009-11-04 14:50:47 as
	Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity [My Copy] Journal of Medicinal Chemistry, Vol. 48, No. 4. (1 February 2005), pp. 1107-1131. by Hwei-Ru Tsou, Elsebe G. Overbeek-Klumpers, William A. Hallett, et al.Marvin F. Reich, M. Brawner Floyd, Bernard D. Johnson, Ronald S. Michalak, Ramaswamy Nilakantan, Carolyn Discafani, Jonathan Golas, Sridhar K. Rabindran, Ru Shen, Xiaoqing Shi, Yu-Fen Wang, Janis Upeslacis, Allan Wissner posted to scifinder sar mgcb kinases egfr convalent_inhibitor cancer by kokphinchooi on 2009-11-04 09:45:30 as
	Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells [My Copy] Biochemical Pharmacology (29 October 2009) by Araceli Arellano-Plancarte, Judith Hernandez-Aranda, Kevin J. Catt, J. Alberto Olivares-Reyes posted to irs hepatocyte egfr akt aii by guhjy on 2009-11-04 03:51:24 as
	EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to Gefitinib [My Copy] N Engl J Med, Vol. 352, No. 8. (24 February 2005), pp. 786-792. by Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, et al.Pasi A. Janne, Olivier Kocher, Matthew Meyerson, Bruce E. Johnson, Michael J. Eck, Daniel G. Tenen, Balazs Halmos posted to scifinder mgcb kinases egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 19:02:41 as
	Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors [My Copy] Journal of Medicinal Chemistry, Vol. 49, No. 4. (1 February 2006), pp. 1475-1485. by Sylvester R. Klutchko, Hairong Zhou, R. Thomas Winters, et al.Tuan P. Tran, Alexander J. Bridges, Irene W. Althaus, Danielle M. Amato, William L. Elliott, Paul A. Ellis, Mary A. Meade, Billy J. Roberts, David W. Fry, Andrea J. Gonzales, Patricia J. Harvey, James M. Nelson, Veronica Sherwood, Hyo-Kyung Han, Gerry Pace, Jeff B. Smaill, William A. Denny, Hollis D. H. Showalter posted to scifinder mgcb egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 18:55:07 as
	Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies [My Copy] Cancer Res, Vol. 67, No. 21. (1 November 2007), pp. 10417-10427. by Zhiwei Yu, Titus J. Boggon, Susumu Kobayashi, et al.Cheng Jin, Patrick C. Ma, Afshin Dowlati, Jeffrey A. Kern, Daniel G. Tenen, Balazs Halmos posted to scifinder kinases egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 18:52:51 as
	Dual MET\|[ndash]\|EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer [My Copy] British Journal of Cancer, Vol. 99, No. 6. (26 August 2008), pp. 911-922. by Z. Tang, R. Du, S. Jiang, et al.C. Wu, D. S. Barkauskas, J. Richey, J. Molter, M. Lam, C. Flask, S. Gerson, A. Dowlati, L. Liu, Z. Lee, B. Halmos, Y. Wang, J. A. Kern, P. C. Ma posted to scifinder mgcb kinases egfr convalent_inhibitor cl-387785 cancer by kokphinchooi on 2009-11-03 18:42:47 as
	A Differential Requirement for the COOH-terminal Region of the Epidermal Growth Factor (EGF) Receptor in Amphiregulin and EGF Mitogenic Signaling [My Copy] Journal of Biological Chemistry, Vol. 274, No. 13. (26 March 1999), pp. 8900-8909. by Lily Wong, Tushar B. Deb, Stewart A. Thompson, Alan Wells, Gibbes R. Johnson posted to mgcb kinases egfr biological_action by kokphinchooi on 2009-11-03 13:00:50 as
	The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies [My Copy] Cancer Cell, Vol. 9, No. 6. (13 June 2006), pp. 485-495. by Hongbin Ji, Danan Li, Liang Chen, et al.Takeshi Shimamura, Susumu Kobayashi, Kate McNamara, Umar Mahmood, Albert Mitchell, Yangping Sun, Ruqayyah Al-Hashem posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:23:58 as
	Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu) [My Copy] European Journal of Cancer, Vol. 43, No. 3. (February 2007), pp. 481-489. by A. Reid, L. Vidal, H. Shaw, J. Debono posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:22:33 as along with 1 person pjasper
	Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer [My Copy] Oncologist, Vol. 12, No. 3. (1 March 2007), pp. 325-330. by Lecia V. Sequist posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:19:10 as along with 1 person pjasper
	The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP [My Copy] Proceedings of the National Academy of Sciences, Vol. 105, No. 6. (12 February 2008), pp. 2070-2075. by Cai-Hong Yun, Kristen E. Mengwasser, Angela V. Toms, et al.Michele S. Woo, Heidi Greulich, Kwok-Kin Wong, Matthew Meyerson, Michael J. Eck posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 12:09:53 as
	A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors [My Copy] Clinical Cancer Research, Vol. 15, No. 7. (1 April 2009), pp. 2552-2558. by Kwok-K Wong, Paula M. Fracasso, Ronald M. Bukowski, et al.Thomas J. Lynch, Pamela N. Munster, Geoffrey I. Shapiro, Pasi A. JÃ¤nne, Joseph P. Eder, Michael J. Naughton, Matthew J. Ellis, Suzanne F. Jones, Tarek Mekhail, Charles Zacharchuk, Jennifer Vermette, Richat Abbas, Susan Quinn, Christine Powell, Howard A. Burris posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-03 11:55:19 as
	Irreversible inhibitors of the erbB family of protein tyrosine kinases [My Copy] Pharmacology & Therapeutics, Vol. 93, No. 2-3. (March 2002), pp. 253-261. by W. Denny posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 23:05:14 as
	Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer [My Copy] Bioorganic & Medicinal Chemistry Letters, Vol. 11, No. 14. (23 July 2001), pp. 1911-1914. by A. Barker posted to mgcb kinases egfr cancer by kokphinchooi on 2009-11-02 17:38:53 as
	Epidermal Growth Factor Receptor Inhibitors in Development for the Treatment of NonâSmall Cell Lung Cancer [My Copy] Clinical Cancer Research, Vol. 12, No. 14. (15 July 2006), pp. 4441s-4445s. by John V. Heymach, Monique Nilsson, George Blumenschein, Vassiliki Papadimitrakopoulou, Roy Herbst posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:13:24 as along with 1 person pjasper
	A specific inhibitor of the epidermal growth factor receptor tyrosine kinase [My Copy] Science, Vol. 265, No. 5175. (19 August 1994), pp. 1093-1095. by D. W. Fry, A. J. Kraker, A. McMichael, et al.L. A. Ambroso, J. M. Nelson, W. R. Leopold, R. W. Connors, A. J. Bridges posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:07:10 as
	An Alternative Inhibitor Overcomes Resistance Caused by a Mutation of the Epidermal Growth Factor Receptor [My Copy] Cancer Res, Vol. 65, No. 16. (15 August 2005), pp. 7096-7101. by Susumu Kobayashi, Hongbin Ji, Yuki Yuza, et al.Matthew Meyerson, Kwok-Kin Wong, Daniel G. Tenen, Balazs Halmos posted to mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:06:09 as along with 1 person pjasper
	Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 21. (24 May 2005), pp. 7665-7670. by Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell, et al.Nadia Godin-Heymann, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, David R. Driscoll, Panos Fidias, Thomas J. Lynch, Sridhar K. Rabindran, John P. McGinnis, Allan Wissner, Sreenath V. Sharma, Kurt J. Isselbacher, Jeffrey Settleman, Daniel A. Haber posted to scifinder neratinib mgcb kinases egfr convalent_inhibitor by kokphinchooi on 2009-11-02 15:04:59 as
	Pressure activates epidermal growth factor receptor leading to the induction of iNOS via NFkappaB and STAT3 in human proximal tubule cells. [My Copy] American journal of physiology. Renal physiology, Vol. 297, No. 1. (July 2009) by Nalini V. Broadbelt, Jie Chen, Randi B. Silver, Dix P. Poppas, Diane Felsen posted to uuo stat pt no nfkb inos egfr by guhjy on 2009-10-21 09:57:53 as
	Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4 [My Copy] Nature Genetics, Vol. 41, No. 10. (30 August 2009), pp. 1127-1132. by Todd D. Prickett, Neena S. Agrawal, Xiaomu Wei, et al.Kristin E. Yates, Jimmy C. Lin, John R. Wunderlich, Julia C. Cronin, Pedro Cruz, Steven A. Rosenberg, Yardena Samuels posted to tyrosine melanoma kinome egfr cancer by renatomilani on 2009-10-09 19:33:56 as
	Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway [My Copy] BMC Systems Biology, Vol. 3, No. 1. (2009), 100. by Richard Orton, Michiel Adriaens, Amelie Gormand, Oliver Sturm, Walter Kolch, David Gilbert posted to signaling pathway modelling erk egfr bioinformatics by renatomilani on 2009-10-07 06:02:14 as along with 5 people colinveal MahalakshmiGunupuru abhishek_tiwari reyez cmzmasek
	miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy [My Copy] Clinical Cancer Research, Vol. 15, No. 16. (15 August 2009), pp. 5060-5072. by Liana Adam, Meng Zhong, Woonyoung Choi, et al.Wei Qi, Milena Nicoloso, Ameeta Arora, George Calin, Hua Wang, Arlene Siefker-Radtke, David McConkey, Menashe Bar-Eli, Colin Dinney posted to mir-200 microrna emt egfr bladder_cancer by tonamswish to the group microRNA on 2009-09-23 15:06:41 as
	microRNA-7 Inhibits the Epidermal Growth Factor Receptor and the Akt Pathway and Is Down-regulated in Glioblastoma [My Copy] Cancer Res, Vol. 68, No. 10. (15 May 2008), pp. 3566-3572. by Benjamin Kefas, Jakub Godlewski, Laurey Comeau, et al.Yunqing Li, Roger Abounader, Michael Hawkinson, Jeongwu Lee, Howard Fine, E. Antonio Chiocca, Sean Lawler, Benjamin Purow posted to mir-7 microrna glioblastoma egfr akt by tonamswish to the group microRNA on 2009-09-21 18:45:45 as along with 2 people oelemento valeriehilgers
	ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. [My Copy] Nature, Vol. 461, No. 7261. (10 September 2009), pp. 287-291. by Diego Alvarado, Daryl E. Klein, Mark A. Lemmon posted to inhibition evolution egfr by renatomilani on 2009-09-11 21:12:17 as
	Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. [My Copy] The Journal of pharmacology and experimental therapeutics, Vol. 312, No. 3. (March 2005), pp. 1043-1054. by Fang Li, Kafait U. Malik posted to vsmc pld egfr akt aii by guhjy on 2009-09-07 16:24:04 as
	Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 27. (8 July 2008), pp. 9284-9289. by Sven Diederichs, Stephanie Jung, S. Michael Rothenberg, Gromoslaw A. Smolen, Barbara G. Mlody, Daniel A. Haber posted to rnai egfr argonaute by guhjy on 2009-08-26 05:02:56 as
	ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability? [My Copy] American journal of physiology. Renal physiology, Vol. 297, No. 3. (September 2009) by W. B. Melenhorst, L. Visser, A. Timmer, M. C. van den Heuvel, C. A. Stegeman, H. van Goor posted to kidney egfr adam by guhjy on 2009-08-25 03:14:41 as
	MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 29. (21 July 2009), pp. 12085-12090. by Masahiro Seike, Akiteru Goto, Tetsuya Okano, et al.Elise D. Bowman, Aaron J. Schetter, Izumi Horikawa, Ewy A. Mathe, Jin Jen, Ping Yang, Haruhiko Sugimura, Akihiko Gemma, Shoji Kudoh, Carlo M. Croce, Curtis C. Harris posted to mirna21 mirna egfr apoptosis by guhjy on 2009-08-23 16:40:31 as along with 1 person valeriehilgers
	Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. [My Copy] The Journal of biological chemistry, Vol. 284, No. 9. (27 February 2009), pp. 5731-5741. by Rebecca J. Webster, Keith M. Giles, Karina J. Price, Priscilla M. Zhang, John S. Mattick, Peter J. Leedman posted to mirna egfr by guhjy on 2009-08-23 16:30:58 as along with 1 person valeriehilgers
	Integration of non-SMAD and SMAD signaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. [My Copy] Thrombosis and haemostasis, Vol. 100, No. 6. (December 2008), pp. 976-983. by Rohan Samarakoon, Paul J. Higgins posted to vsmc tgfb smad-independent smad ref pai1 erk egfr by guhjy on 2009-08-23 13:20:21 as
	Suppression of PAI-1 expression through inhibition of the EGFR-mediated signaling cascade in rat kidney fibroblast by ascofuranone. [My Copy] Journal of cellular biochemistry, Vol. 107, No. 2. (15 May 2009), pp. 335-344. by Hyun-Ji J. Cho, Jeong-Han H. Kang, Teoan Kim, et al.Kwang-Kyun K. Park, Cheorl-Ho H. Kim, In-Seon S. Lee, Kwan-Sik S. Min, Junji Magae, Hiroo Nakajima, Young-Seuk S. Bae, Young-Chae C. Chang posted to tgfb ref pai1 nrk49f fbl egfr by guhjy on 2009-08-23 13:17:57 as
	TGF-beta1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy. [My Copy] Journal of oncology, Vol. 2009 (2009) by Rohan Samarakoon, Craig E. Higgins, Stephen P. Higgins, Paul J. Higgins posted to tgfb pai1 egfr cancer by guhjy on 2009-08-23 13:16:41 as
	Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism. [My Copy] American journal of physiology. Renal physiology, Vol. 297, No. 1. (July 2009) by Frank Helle, Charlotte Jouzel, Christos Chadjichristos, et al.Sandrine Placier, Martin Flamant, Dominique Guerrot, Hélène François, Jean-Claude C. Dussaule, Christos Chatziantoniou posted to inhibitor egfr ckd by guhjy on 2009-08-23 02:01:08 as

Note: You may cite this page as: http://www.citeulike.org/tag/egfr

Result page: 1 2 3 4 5 6 7 8 9 Next

cancer	67
inhibitor	43
ref	32
nsclc	31
transactivation	29
mutation	25
review	25
tgfb	25
akt	23
erk	21
kinases	21
mgcb	21
aii	20
fbl	20
pt	20
ros	19
egf	16
convalent_inhibitor	15
p38	14
signaling	14
src	14
therapy	14
gefitinib	13
iressa	13
mapk	13
breast	12
erbb	12
pkc	12
activation	11
adam	11
apoptosis	11
her2	11
internalization	11
mc	11
nrk49f	11
pi3k	11
scifinder	11
1	10
phosphatase	10
cite	9
colon_cancer	9
kinase	9
receptor	9
resistance	9
structure	9
erbb2	8
gpcr	8
kras	8
mouse	8
mtor	8
proliferation	8
promoter	8
t669	8
tki	8
dimerization	7
emt	7
endocytosis	7
hg	7
oral	7
amplification	6
drug	6
erlotinib	6
glioblastoma	6
kidney	6
lung	6
met	6
neratinib	6
pai1	6
phosphorylation	6
rtk	6
vsmc	6
age	5
collagen	5
fibronectin	5
fulltext	5
hcc	5
integrin	5
lung_cancer	5
ms	5
network	5
nfkb	5
p53	5
ppi	5
pten	5
stat	5
t790m	5
aldosterone	4
biological_action	4
cl-387785	4
dm	4
drosophila	4
eml4-alk	4
hbegf	4
microrna	4
mir-200	4
mutant	4
ptp	4
ptp1b	4
s6k	4
tyrosine	4

Tag egfr [at least 200 articles] Export

Related Tags